SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.69+2.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alper H.YUKSEL who wrote (16134)3/1/1998 8:26:00 AM
From: Russian Bear  Read Replies (3) of 32384
 
Everyone,

Ligand just announced the release of expanded phase I/II Panretin gel studies for KS:

biz.yahoo.com

A quick look through the release failed to identify any substantial, new information. Did I miss anything important in the statement?

RB

P.S. I am really, really curious about the LLY compound decision. My "gut feeling" is that the deadline for a final decision has been extended, and we will all need to wait a bit longer.

P.P.S. I did find the following quote interesting (re: oral Panretin phase II:)

"We are encouraged by the data from these two Phase II studies and plan to complete development work and file an NDA in 1999."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext